Similar articles

• Chemical modification of ansamitocins. III. Synthesis and biological effects of 3-acyl esters of maytansinol.

  Kawai A, Akimoto H, Kozai Y, Ootsu K, Tanida S, Hashimoto N, Nomura H. Kawai A, et al. Chem Pharm Bull (Tokyo). 1984 Sep;32(9):3341-51. Chem Pharm Bull (Tokyo). 1984. PMID: 6441645 No abstract available.
• Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.

  Perchellet EM, Ladesich JB, Magill MJ, Chen Y, Hua DH, Perchellet JP. Perchellet EM, et al. Anticancer Drugs. 1999 Jun;10(5):489-504. Anticancer Drugs. 1999. PMID: 10477169
• Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics.

  Tanida S, Higashide E, Yoneda M. Tanida S, et al. Antimicrob Agents Chemother. 1979 Jul;16(1):101-3. doi: 10.1128/AAC.16.1.101. Antimicrob Agents Chemother. 1979. PMID: 475367 Free PMC article.
• Maytansine.

  Issell BF, Crooke ST. Issell BF, et al. Cancer Treat Rev. 1978 Dec;5(4):199-207. doi: 10.1016/s0305-7372(78)80014-0. Cancer Treat Rev. 1978. PMID: 367597 Review. No abstract available.
• Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

  Hamel E. Hamel E. Cell Biochem Biophys. 2003;38(1):1-22. doi: 10.1385/CBB:38:1:1. Cell Biochem Biophys. 2003. PMID: 12663938 Review.